Connect with us

Technology

A*STAR And MojiaBio To Develop Next-gen Sustainable Biomanufacturing Platform In Singapore

Published

on

SINGAPORE, Feb. 28, 2025 /PRNewswire/ — This initiative aims to produce eco-friendly bio-based molecules from low-cost, eco-friendly sources. Key benefits include:

Cost-parity with conventional methods: Unlike existing bio-based molecules production, this initiative aims to achieve cost-parity with conventional processes by utilising low-cost renewable sources like methanol.

Wide-ranging industry applications: The sustainable bio-based molecules produced can be used for wide-ranging industrial applications in textiles, automotive, personal care, and coatings industries.

Boosting Singapore’s green economy: This effort strengthens Singapore’s leadership in the global bioeconomy, which can lead to high-value job creation in sustainable biomanufacturing.

SINGAPORE – MojiaBio, a leading innovator in green chemistry and sustainable biomanufacturing, will be developing an SGD 44.8 million state-of-the-art Sustainable Biomanufacturing Technology Platform (SBTP) with the Agency for Science, Technology and Research (A*STAR). By integrating advanced synthetic biology and bioprocessing innovations, the SBTP aims to position Singapore as a global leader in sustainable biomanufacturing, accelerating the transition to a circular bioeconomy and net-zero future.

Unlike other existing bio-based molecules in the market, the SBTP aims to pioneer the production of a range of high-value bio-based molecules that are cost-competitive and serve the needs of various industries. This is made possible due to the innovative use of cost-effective sources like methanol and ethylene glycol, which enables the platform to produce scalable, sustainable alternatives to conventional chemical processes. This includes the production of 1,3-propanediol (PDO), a key ingredient for a broad array of industries such as skincare products, coatings and biodegradable plastics.

Building Singapore’s Capabilities in Green Biomanufacturing

The global market for green chemicals is projected to reach USD 200 billion (around SGD 270 billion) by 2030, driven by increasing demand for sustainable alternatives to their fossil-based counterparts. This collaboration will help Singapore build up our synthetic biology capabilities, which will help position us to capture a share of this growing market and contribute to the development of new economic opportunities in the green economy.

At the heart of the SBTP is MojiaBio’s proprietary Cn+Bio™ pathway and OrthBio® bioconversion process, designed to convert low-cost, renewable sources into bio-based molecules. This will be developed in close collaboration with A*STAR Singapore Institute of Food and Biotechnology Innovation (A*STAR SIFBI)—which will provide expertise on enzyme engineering—to ensure a faster, more reliable, and higher-yield conversion.

“The SBTP will not only produce bio-based molecules but also support downstream application research to synthesise high-value sustainable products for different industries,” said Dr Ramon Gonzalez, MojiaBio CSO. “Through our partnership with A*STAR, we will be able to accelerate the commercialisation of green PDO to meet the growing demands and needs of the market.”

The SBTP leverages advanced synthetic biology and integrates the National University of Singapore (NUS)’ computational modelling expertise to engineer enzymes and microbial strains, optimising them as biocatalysts. Unlike conventional fermentation methods, the platform operates independently of its host cell metabolism, which significantly enhances energy efficiency, scalability, and sustainability while reducing production costs.

Professor Tan Sze Wee, Assistant Chief Executive from A*STAR Biomedical Research Council said, “The SBTP marks a significant step forward in sustainable biomanufacturing for Singapore, demonstrating how synthetic biology can unlock cost-effective productions of scalable value-added ingredient alternatives. By leveraging synthetic biology and enzyme engineering capabilities at A*STAR SIFBI and A*STAR Institute of Sustainability for Chemicals, Energy and Environment (A*STAR ISCE2) and forming strategic private-public partnerships, we are laying the foundation for further advancements in sustainable biomanufacturing across multiple industries. This collaboration will not only accelerate Singapore’s bioeconomy growth but also underscore our commitment to advancing in value-added ingredient innovation and green technologies.”

Lim Wey-Len, Executive Vice President, Singapore Economic Development Board (EDB) said: “Singapore has been developing our capabilities in industrial biotechnology as part of a push for sustainable manufacturing. The SBTP demonstrates how leading companies can partner Singapore’s research ecosystem to innovate and commercialise novel products that improve the quality of life, while meeting sustainability commitments. We welcome more like-minded companies to create solutions through Singapore that can further grow Asia’s bioeconomy sector.”

Advancing Green Economy: Building a Sustainable Future Together

The SBTP aligns with the Singapore Green Plan 2030 targets and global sustainability goals, such as reducing carbon emissions and promoting a circular economy. Compared to conventional methods, bio-based molecules produced through this platform offer significant environmental benefits over conventional processes, including:

Reduced energy use: Renewable sources (e.g. methanol and ethylene glycol) require less energy to process.

Lower carbon footprint: Bio-based production typically emits significantly less carbon dioxide than conventional chemical processes by around 60%.

Fewer pollutants: Bio-based methods produce fewer harmful emissions, such as nitrogen oxides (NOx) and sulphur oxides (SOx).

“This collaboration exemplifies our vision to create impactful, sustainable solutions for the future,” said Dr Gonzalez. “MojiaBio is also making strides to establish our operational headquarters and a dedicated research laboratory in Singapore to accelerate commercialisation of other green chemicals to contribute to Singapore’s bioeconomy and the global transition toward sustainability.”

1 “Green Chemicals Market – Global Industry Assessment and Forecast.” Vantage Market Research, 4 July 2023, www.vantagemarketresearch.com/industry-report/green-chemicals-market-1347

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is Singapore’s lead public sector R&D agency. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit the economy and society. As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by improving societal outcomes in healthcare, urban living, and sustainability. A*STAR plays a key role in nurturing scientific talent and leaders for the wider research community and industry. A*STAR’s R&D activities span biomedical sciences to physical sciences and engineering, with research entities primarily located in Biopolis and Fusionopolis.

About A*STAR Singapore Institute of Food and Biotechnology Innovation (A*STAR SIFBI)

A*STAR Singapore Institute of Food and Biotechnology Innovation (A*STAR SIFBI)’s vision is to be an innovation engine for health and well-being, focusing on the Asian phenotype. Our two strategic pillars are: 1) Developing sustainable, value-added ingredients for food and consumer care; and 2) Optimizing health and wellbeing within the Asian phenotype. We prioritize consumer acceptance, considering taste, texture, and nutrition, alongside sustainable and safe food production. Understanding sensory preferences and the Asian phenotype allows us to tailor food designs to meet consumer needs and improve population health and wellness. We directly impact food resilience, population health, economic growth, and talent development. We envision Singapore as a leading hub for Asian food and nutrition research, fostering industry partnerships and regional collaboration to advance this critical field. This is achieved through public-private partnerships locally and globally. Learn more about SIFBI.

About MojiaBio

MojiaBio is a pioneering leader in industrial biomanufacturing, revolutionizing the production of commodities, materials, and chemicals through sustainable and green processes. By leveraging cutting-edge technologies and demand-driven innovation, MojiaBio is committed to creating transformative solutions that shape the future of multiple industries. For more information on MojiaBio.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/astar-and-mojiabio-to-develop-next-gen-sustainable-biomanufacturing-platform-in-singapore-302388357.html

SOURCE MojiaBio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Pillsbury Notice of Data Breach

Published

on

By

NEW YORK, July 18, 2026 /PRNewswire/ — Pillsbury Winthrop Shaw Pittman LLP (“Pillsbury”) was among many law firms targeted by sophisticated social engineering attempts in an incident last year. While the firm quickly detected and blocked the activity, an unauthorized actor was able to access some of the firm’s documents during a short window of time. Pillsbury notified any impacted clients last year and undertook a detailed process to review the accessed documents for personal information. Pillsbury then began notifying individuals whose personal information was affected. That process is now complete, and today, Pillsbury is publishing substitute notice as a final step.

For more information, please visit the substitute notice on our website at https://www.pillsburylaw.com/en/breach-notice.html

View original content to download multimedia:https://www.prnewswire.com/news-releases/pillsbury-notice-of-data-breach-302828892.html

SOURCE Pillsbury Winthrop Shaw Pittman LLP

Continue Reading

Technology

From Remote Racing to Embodied AI: Fibocom and Intedigo Bring 5G Bidirectional Data Transmission into Real-World Applications

Published

on

By

SHANGHAI, July 18, 2026 /PRNewswire/ — From July 17 to 20, Fibocom and Intedigo will jointly present a cross-regional, beyond-visual-line-of-sight (BVLOS) teleoperation demonstration at Booth H3-C408 during the World Artificial Intelligence Conference (WAIC) 2026. Visitors will be able to enter a remote driving cockpit and control a real race car located at HURA PARK in Jiading, Shanghai, steering, accelerating, and braking in real time while experiencing how 5G connectivity enables remote operation.

More than an immersive driving experience, the demonstration provides a live validation of 5G bidirectional data transmission for embodied AI teleoperation. The vehicle continuously sends live track video, vehicle status, and operating data to the remote cockpit, while control commands are transmitted back to the vehicle, creating a closed-loop teleoperation system. Stable, low-latency, and highly reliable connectivity is essential for high-dynamic maneuvers such as high-speed cornering, precision braking, and continuous lane changes.

Developed by Intedigo, the remote driving system connects a real race car with an immersive remote driving cockpit. It supports 1080p@60Hz video transmission, glass-to-glass (G2G) video latency of less than 80 ms, and control latency of less than 10 ms. The demanding racing environment magnifies differences in video continuity and control responsiveness, making communications performance directly perceptible, measurable, and verifiable.

At the joint demonstration, Fibocom’s FM160 5G module provides cellular connectivity for the system. Powered by the Qualcomm Snapdragon™ X62 5G Modem-RF System, the FM160 supports SA and NSA network architectures as well as 3GPP Release 16. On the downlink, it supports NR Carrier Aggregation (NR CA) with bandwidth of up to 120 MHz, delivering peak speeds of up to 3.5 Gbps in NSA mode and 2.5 Gbps in SA mode. On the uplink, it supports UL MIMO and delivers peak speeds of up to 900 Mbps in SA mode. These capabilities support the continuous transmission of HD video and vehicle status data, along with reliable delivery of control commands.

As embodied AI moves into factories, data centers, logistics operations, and industrial parks, robots are becoming increasingly capable of performing tasks autonomously. Yet complex environments, unexpected events, and edge cases still require Human-in-the-Loop (HITL) remote intervention to help ensure safe and reliable operation.

Daniel Liu, CEO of Intedigo, said:

“5G represents the pinnacle of human communications and the starting point of machine communications. In the past, communications connected people to people; in the future, they will connect people to robots and robots to robots. Remote racing is simply the easiest entry point for people to understand this concept. What we are truly validating is a communications system capable of supporting remote collaboration for embodied AI. HURA makes low-latency remote driving a tangible experience, while RoBOX extends this capability to robots and a broader range of intelligent terminals. Together with Fibocom, we hope to enable more machines to receive remote assistance whenever needed while remaining continuously connected and operating reliably.”

Simon Tao, VP of Wireless Solutions Business Group and General Manager of MBB BU at Fibocom, said:

“As embodied AI enters real-world industrial environments, reliable connectivity will become the foundation for telemetry feedback, remote control and operational management. Fibocom’s 5G solutions, represented by FM160, provide the cellular connectivity required for continuous on-site data transmission and reliable control command delivery. Fibocom will continue collaborating with ecosystem partners such as Intedigo to bring cellular connectivity to more robots, autonomous machines and mobile intelligent terminals, enabling embodied AI systems to stay continuously connected and respond reliably in real-world applications.”

From remote race cars to robots, unmanned equipment, and mobile intelligent terminals, 5G is evolving from connecting people to connecting machines. This joint demonstration makes the capabilities of 5G bidirectional data transmission directly perceptible, experiential, and verifiable, helping pave the way for embodied AI to scale across real-world applications.
 

About Fibocom

Fibocom, founded in 1999, is China’s first wireless communication module company listed on both the A-share and H-share markets (300638.SZ, 0638.HK). As a global leading provider of wireless communication modules and AI solutions, Fibocom leverages wireless communication and artificial intelligence as its core technologies to provide integrated hardware and software solutions that empower industry applications. These solutions accelerate the transformation from “Connect Everything” to “Intelligent Connectivity” across diverse industries.

Fibocom’s one-stop solutions encompass cellular communication, AI, automotive, and GNSS modules, as well as AI toolchains, supporting industry-side and mainstream large model integration, and providing AI Agent, global connectivity, and cloud services, driving the digital intelligence upgrades in industries such as robotics, consumer electronics, low-altitude economy, intelligent transportation, smart retail, and smart energy.

View original content to download multimedia:https://www.prnewswire.com/news-releases/from-remote-racing-to-embodied-ai-fibocom-and-intedigo-bring-5g-bidirectional-data-transmission-into-real-world-applications-302828996.html

SOURCE Fibocom Wireless Inc.

Continue Reading

Technology

DR. PHONE FIX ANNOUNCES SECOND TRANCHE CLOSING OF NON-BROKERED CONVERTIBLE DEBENTURE UNIT FINANCING

Published

on

By

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

EDMONTON, AB, July 18, 2026 /CNW/ — Dr. Phone Fix Canada Corporation (“Dr. Phone Fix” or the “Company”) (TSXV: DPF) is pleased to announce that, further to its news release dated May 19, 2026 and June 24, 2026 (the “Prior News Releases”), it has closed the second tranche of its non-brokered private placement (the “Offering”) of convertible debenture units of the Company (each, a “Unit”). The Company issued 726 Units, at a price of $1,000 per Unit, for aggregate gross proceeds of $726,000. Each Unit is comprised of (i) one $1,000 principal amount unsecured convertible debenture of the Company (a “Convertible Debenture”) and (ii) 3,125 common share (“Common Share”) purchase warrants of the Company (each, a “Warrant”). Additional detail on the Offering, including terms of the Convertible Debentures and Warrants, is set out in the Prior News Releases.

In connection with the Offering, the Company paid a finder’s fee consisting of an aggregate cash fee of $50,820 and issued an aggregate of 317,625 common share purchase warrants of the Company (each, a “Finder’s Warrant”) to certain qualified arm’s length parties. Each Finder’s Warrant is exercisable to acquire one Common Share of the Company at an exercise price of $0.22 prior to the date that is 24 months from the date of issuance.

All securities issued pursuant to the Offering, including any Common Shares issuable upon conversion of the Convertible Debentures or exercise of the Warrants and Finder’s Warrants, are subject to a statutory hold period of four months and one day from the closing of the Offering, in accordance with applicable securities laws and TSX Venture Exchange (the “TSXV”) policies. 

The Offering remains subject to final acceptance of the TSXV.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described in this news release in the United States. Such securities have not been, and will not be, registered under the U.S. Securities Act, or any state securities laws, and, accordingly, may not be offered or sold within the United States, or to or for the account or benefit of persons in the United States or “U.S. Persons”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

About Dr. Phone Fix

Dr. Phone Fix is a national, award-winning, eco-friendly, and customer-centric leader in Canada’s cell phone and electronics repair and certified pre-owned device industry. Founded in 2019, the Company now operates 44 retail locations nationwide through a standardized and scalable operating platform designed to support consistent execution across multiple markets, delivering fast, reliable, and environmentally conscious repair services alongside a curated selection of certified pre-owned devices and premium accessories. Dr. Phone Fix maintains strong partnerships with OEMs and certified suppliers, ensuring consistently high-quality standards across its national footprint. With a focus on responsible device lifecycle management, customer service, and operational discipline, Dr. Phone Fix continues to set the benchmark for device care and resale in Canada.

www.docphonefix.com

NEITHER THE TSXV NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.

Forward-Looking Information and Cautionary Statements

Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include statements relating to: the final acceptance of the Offering by the TSXV; and the expected use of proceeds following the closing of the Offering. Forward-looking information in this news release is based on certain assumptions and expected future events, namely: the Company’s financial condition and development plans do not change as a result of unforeseen events; the TSXV will provide its final acceptance of the Offering; and the Company will be able to obtain the financing required in order to develop and continue its business and operations. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the Company’s inability to obtain TSXV final acceptance for the Offering; the potential failure to complete the balance of the Offering or to raise the full anticipated gross proceeds; market conditions and investor demand for the Company’s securities; the Company’s inability to deploy the proceeds as currently intended; and general economic and market conditions. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

 

SOURCE Dr. Phone Fix

Continue Reading

Trending